CAR Modal

Human

Same Tab

Below is a collection of resources to learn more about the latest innovations in orthobiologics products and techniques.

AAOS 2025 Annual Meeting: Orthobiologics Feature Products

Orthobiologics

Not Hidden

English  - en

application/pdf

A document containing information about Arthrex products and product lines.

Ein Dokument mit Informationen über Arthrex Produkte und Produktlinien.

Broschüren

Documento contendo informações sobre produtos e linhas de produtos da Arthrex.

Brochuras

Documento que contiene información sobre los productos y líneas de productos de Arthrex.

Folletos

Brochures

Orthobiologics New Product Spotlight AutoCart Technique ™ Arthrex Shaver Blades Resect viable tissue Arthroscopic, Single-Stage Cartilage Restoration GraftNet™ System Resect and Collect™ Matrix-Augmented Cartilage Implantation, Simplified Everything you need to harvest and reimplant particulate osteochondral tissue in a single procedure, including point-ofcare preparation of PRP and an autologous thrombin solution for enhanced bone ingrowth and graft fixation.1,2 Learn more about the Arthrex cartilage repair algorithm at JointPreservation.Arthrex.com BioCartilage® Extracellular Matrix The ideal scaffold References 1. Drakos MC, Eble SK, Cabe TN, et al. Comparison of functional and radiographic outcomes of talar osteochondral lesions repaired with micronized allogenic cartilage extracellular matrix and bone marrow aspirate concentrate vs microfracture. Foot Ankle Int. 2021;42(7):841-850. doi:10.1177/1071100720983266 2. Irwin RM, Bonassar LJ, Cohen I, et al. The clot thickens: autologous and allogeneic fibrin sealants are mechanically equivalent in an ex vivo model of cartilage repair. PLoS One. 2019;14(11):e0224756. doi:10.1371/journal.pone.0224756 Thrombinator™ System Autologous sealant Arthrex ACP® System Autologous growth factors Comprehensive PRP Solutions Angel® System The Angel concentrated platelet-rich plasma (cPRP) system is the only fully automated system with proprietary 3-sensor technology for preparation of adjustable cellular concentrations of PRP and cPRP from bone marrow aspirate (BMA). ACP Max™ PRP System The ACP Max triple-syringe system uses a double-spin regimen to produce PRP from 30 mL, 60 mL, or 90 mL of whole blood (WB), resulting in up to 12× over baseline platelet concentration and a greater than 97% reduction of neutrophils.1-3 Arthrex ACP® Double-Syringe System The Arthrex ACP (autologous conditioned plasma) double-syringe system allows for rapid and efficient concentration of platelets from 15 mL of WB, providing a PRP that is low in neutrophils in just 5 minutes. References 1. Arthrex, Inc. Data on file (APT 5368). Naples, FL; 2021. 2. Arthrex, Inc. Data on file (APT 5535). Naples, FL; 2022. 3. Arthrex, Inc. Data on file (APT-5756). Naples, FL; 2022. BioACL™ Technique Improve ACL Bone Tunnel Healing and Redefine Outcomes With Next-Generation Biologics Better patient-reported outcomes, greater range-of-motion, and less bone tunnel widening1 Bone tunnels are filled with the BioACL composite mixture to promote and accelerate tibial and femoral tunnel remodeling.1 Patient A 2 years post-op Non-augmented ACL reconstruction Patient B 2 years post-op BioACL reconstruction Reference Learn more about the BioACL technique 1. Lavender CD, Schaver AL, Taylor S, et al. Anterior cruciate ligament reconstruction augmentation with bone marrow aspirate concentrate, demineralized bone matrix, and suture tape shows no difference in outcomes—but faster functional recovery— versus non-augmented anterior cruciate ligament reconstruction. Arthroscopy. doi:10.1016/j.arthro.2024.06.042 Give Patients the Freedom of Faster Functional Recovery1 AlloSync™ Pure Demineralized Bone Matrix Vortex™ Threaded Recovery Needle Maximize the concentration of medicinal signaling cells (MSCs) from bone marrow aspirate harvested using the Vortex threaded recovery needle. Fill ACL tunnels with an osteoinductive, cuttingedge bone graft made of 100% demineralized bone matrix, with no extrinsic carriers, that resists irrigation. QuadLink™ Presutured Construct Angel® cPRP from BMA The only presutured quadriceps allograft, presized and presutured with #2 FiberLoop® with FiberTag™ suture. Compatible with ACL TightRope® II implants. Process MSCs from bone marrow aspirate with the best-in-class BMA processing system. GraftNet™ Autologous Tissue Collector Easily collect autologous bone into a sterile filtered chamber to enhance bone stabilization and biological healing. References 1. Lavender CD, Schaver AL, Taylor S, et al. Anterior cruciate ligament reconstruction augmentation with bone marrow aspirate concentrate, demineralized bone matrix, and suture tape shows no difference in outcomes—but faster functional recovery—versus non-augmented anterior cruciate ligament reconstruction. Arthroscopy. doi:10.1016/j.arthro.2024.06.042 CuffMend™ Rotator Cuff Augmentation System Fast Fixation. Supports Healing.1,2 Cur ve d St r a i g ht ArthroFLEX® Human Dermal Allograft Provides integration and supplemental support to the native tissue while reducing the incidence of retears.3-5 Implantation of the CuffMend system is designed to be completed in <10 minutes Applications for revision cuff repair, poor tissue quality, and treating patients with comorbidities that impede healing.6 ArthroFLEX is a registered trademark of LifeNet Health. FiberStitch™ RC 1.5 Implant Allows for quick, secure, suturebased medial graft fixation. References 1. Ely EE, Figueroa NM, Gilot GJ. Biomechanical analysis of rotator cuff repairs with extracellular matrix graft augmentation. Orthopedics. 2014;37(9):608-614. doi:10.3928/01477447-20140825-05 2. Smith MJ, Bozynski CC, Kuroki K, Cook CR, Stoker AM, Cook JL. Comparison of biologic scaffolds for augmentation of partial rotator cuff tears in a canine model. J Shoulder Elbow Surg. 2020;29(8):15731583. doi:10.1016/j.jse.2019.11.028 3. Gilot GJ, Alvarez-Pinzon AM, Barcksdale L, Westerdahl D, Krill M, Peck E. Outcome of large to massive rotator cuff tears repaired with and without extracellular matrix augmentation: a prospective comparative study. Arthroscopy. 2015;31(8):1459-1465. doi:10.1016/j. arthro.2015.02.032 4. Bailey JR, Kim C, Alentorn-Geli E, et al. Rotator cuff matrix augmentation and interposition: a systematic review and meta-analysis. Am J Sports Med. 2019;47(6):1496-1506. doi:10.1177/0363546518774762 5. Hartzler RU, Softic D, Qin X, Dorfman A, Adams CR, Burkhart SS. The histology of a healed superior capsular reconstruction dermal allograft: a case report. Arthroscopy. 2019;35(10):2950-2958. doi:10.1016/j.arthro.2019.06.024 6. Kwon J, Kim SH, Lee YH, Kim TI, Oh JH. The Rotator Cuff Healing Index: A new scoring system to predict rotator cuff healing after surgical repair. Am J Sports Med. 2019;47(1):173-180. doi: 10.1177/0363546518810763 BoneSync™ Calcium Phosphate Cement The Answer to Poor Lateral Row Bone Quality Fast setting to allow immediate supplemental fixation and strength to a surgical repair site1 with a collagen-infused calcium phosphate Anchor Fixation at the First Punch Addition of BoneSync bone void filler can significantly increase anchor fixation strength in poor-quality bone.1 Ideal Porosity for Integration Infused collagen provides a macroporosity structure allowing for osseointegration that is resorbed and replaced with new bone. Reference 1. Arthrex, Inc. Data on file (APT-04387). Naples, FL; 2019. Inject and Set The porous calcium phosphate is injectable and hardware-compatible, enhancing structural bone support. Learn more about BoneSync calcium phosphate JumpStart® Antibacterial Dressings Extend Infection Control Beyond the Operating Room Powered by Advanced Microcurrent Technology®, JumpStart antibacterial wound dressings are inspired by the body’s natural electrical healing process. Elemental silver and elemental zinc microcell batteries generate an electric field when hydrated, to provide protection against a broad spectrum of bacteria1-3 and support the body’s natural electrical healing process. References 1. Kim H, Makin I, Skiba J, et al. Antibacterial efficacy testing of a bioelectric wound dressing against clinical wound pathogens. Open Microbiol J. 2014;8:15-21. doi:10.2174/1874285801408010015 2. Banerjee J, Das Ghatak P, Roy S, et al. Silver-zinc redox-coupled electroceutical wound dressing disrupts bacterial biofilm. PLoS One. 2015;10(3):e0119531. doi:10.1371/journal.pone.0119531 3. Kim H, Izadjoo MJ. Antibiofilm efficacy evaluation of a bioelectric dressing in mono- and multi-species biofilms. J Wound Care. 2015;24 Suppl 2:S10-S14. doi:10.12968/jowc.2015.24.Sup2.S10 arthrex.com © 2025-02 Arthrex, Inc. All rights reserved. evBR1-002486-en-US_E JumpStart® ClearFit™ Dressings Features advanced microcurrent technology, with a clear gentle adhesive layer.

Orthobiologics - New Product Spotlight

The Arthrex ACP® double-syringe system provides rapid and efficient concentration of platelets and growth factors from platelet-rich plasma (PRP) for use at the patient’s point of care. Its unique double-syringe design allows for safe and convenient handling of the biologic treatment.

video

Animations demonstrating the features and benefits of a specific product.

Animationen, die die Funktionen und Vorteile eines bestimmten Produkts demonstrieren.

Produktdemonstrationen

Animações demonstrando os recursos e benefícios de um produto específico.

Vídeos de demonstração de produtos

Animaciones que demuestran las características y beneficios de un producto específico.

Videos de demostración de productos

Product Demonstrations

Arthrex ACP® Double-Syringe System

Spine

JumpStart® antimicrobial wound dressing with Advanced Microcurrent Technology®* is used for the management of surgical incision sites. Embedded in the dressing are microcell batteries made of silver and zinc, which generates an electrical current and kills a broad spectrum of harmful pathogens, including multidrug-resistant and biofilm-forming bacteria to help reduce the risk of infection.
*Advanced MicroCurrent Technology is a registered trademark of Vomaris Wound Care, Inc.

A general overview including the relevant steps of an Arthrex surgical technique. These animations always include a voice-over explaining the process.

Eine allgemeine Übersicht, einschließlich der relevanten Schritte einer Arthrex Operationsanleitung. Diese Animationen enthalten immer Voice-Overs, die den Prozess erklären.

Operationstechnik-Animationen

Visão geral incluindo as etapas relevantes de uma técnica cirúrgica Arthrex. Essas animações sempre incluem uma narração explicando o processo.

Animações de técnicas cirúrgicas

Descripción general que incluye los pasos relevantes de una técnica quirúrgica de Arthrex. Estas animaciones siempre incluyen una voz en off que explica el proceso.

Animaciones de técnicas quirúrgicas

Surgical Technique Animations

JumpStart® Antimicrobial Wound Dressing

Quick Facts

Dados curtos

Datos breves

Quick Facts IntraOsseous BioPlasty® Technique (IOBP® Technique) Subchondral bone marrow lesions (BMLs) are important to identify and treat, as they are highly predictive of total knee arthroplasty (TKA)1 BMLs can result from1: Subchondral insufficiency 57% 97% Increased chance of a patient needing TKA within two years if BMLs are left untreated2 Greater intraosseous pressures measured in medial and lateral femoral condyles of patients with BMLs than in patients without BMLs3 fractures Osteoarthritis Avascular necrosis Core decompression (CD) alone is not effective at treating necrotic lesions4 Success at 5-Year Follow-up Acute trauma 77% Chronic trauma Delayed bone union Osteoporosis Bone repair after BMA injection was observed in 88% of patients5 Before and After IOBP Procedure 10 100 90 8 80 70 6 60 5 50 40 4 30 2 0 P ain Visual Analog Scale (VAS) I nternational Knee Documentation Committee (IKDC) Before After 20 10 0 Before After The IOBP technique is associated with clinically significant improvements in pain and function3 arthrex.com © 2021 Arthrex, Inc. All rights reserved. LI1-000152-en-US_B CD and BMA CD alone Achieve Joint Preservation Through Comprehensive Treatment of BMLs: 1.19% At 15-year (on average) follow-up, treatment with cell therapy resulted in per-year revision rates similar to TKA (1.19% versus 1.0%, respectively)6 27% Multiple kit options tailored to treat BMLs of the knee, hip, and talus IOBP core decompression device has a 3.3 mm diameter that can achieve a 7 mm cortex-sparing decompression The IOBP technique includes use of the Arthrex Angel® cPRP and bone marrow processing system and AlloSync™ Pure demineralized bone matrix to encourage bone remodeling and repair Simple procedure with a low complication rate; patients can bear weight as tolerated, allowing them an early return to function and activities of daily living7,8 References 1. Bonadio MB, Filho AGO, Helito CP, Stump XM, Demange MK. Bone marrow lesion: image, clinical presentation, and treatment. Magn Reson Insights. 2017;10:1178623X17703382. doi:10.1177/1178623X17703382 2. Tanamas SK, Wluka AE, Pelletier JP, et al. Bone marrow lesions in people with knee osteoarthritis predict progression of disease and joint replacement: a longitudinal study. Rheumatology (Oxford). 2010;49(12):2413-2419. doi:10.1093/ rheumatology/keq286 3. Kasik CS, Martinkovich S, Mosier B, Akhavan S. Short-term outcomes for the biologic treatment of bone marrow edema of the knee using bone marrow aspirate concentrate and injectable demineralized bone matrix. Arthrosc Sports Med Rehabil. 2019;1(1):e7-e14. doi:10.1016/j. asmr.2019.07.001 4. Gangji V, De Maertelaer V, Hauzeur JP. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone. 2011;49(5):1005-1009. doi:10.1016/j.bone.2011.07.032 5. Hernigou PH, Mathieu G, Poignard A. Percutaneous autologous bone-marrow grafting for nonunions. Surgical technique. J Bone Joint Surg Am. 2006 Sep;88 Suppl 1 Pt 2:322-7. doi:10.2106/JBJS.F.00203 6. Hernigou P, Delambre J, Quiennec S, Poignard A. Human bone marrow mesenchymal stem cell injection in subchondral lesions of knee osteoarthritis: a prospective randomized study versus contralateral arthroplasty at a mean fifteen-year followup. Int Orthop. 2021;45(2):365-373. doi:10.1007/s00264-020-04571-4 7. Martin JR, Houdek MT, Sierra RJ. Use of concentrated bone marrow aspirate and platelet rich plasma during minimally invasive decompression of the femoral head in the treatment of osteonecrosis. Croat Med J. 2013;54(3):219224. doi:10.3325/cmj.2013.54.219 8. Tanamas SK, Wluka AE, Pelletier JP, et al. Bone marrow lesions in people with knee osteoarthritis predict progression of disease and joint replacement: a longitudinal study. Rheumatology. 2010;49(12):2413-2419. doi:10.1093/rheumatology/keq286

IntraOsseous BioPlasty® Technique

This animation demonstrates BoneSync™ calcium phosphate cement for augmentation of poor-quality bone surrounding lateral-row anchors during a FiberTak® SpeedBridge™ rotator cuff repair.&nbsp;

BoneSync™ Calcium Phosphate Cement Animation

Bonesync calcium phosphate cement is a collagen enhanced bone void filler. This fast setting, fast remodeling biomimetic bone void filler uses a straightforward mixing system to deliver an injectable putty. The one cc size offering is optimal for instances where a small bone void needs augmentation, such as poor quality bone when placing the lateral SwiveLock anchors during a FiberTak SpeedBridge repair. When additional support to the surrounding poor quality bone is needed. Bonesync cement uses a mixing protocol that quickly results in an easily injectable cement. Draw 0.8ml of saline into a syringe. Remove the clear cap of the BoneSync powder syringe and thread the two syringes. Inject the saline into the BoneSync powder syringe and mix thoroughly for 60s. Move the mixed BoneSync cement to the delivery syringe. If excess air is present, pull back on the plunger, then press on the plunger to expel all the air in the syringe. After a punch is used to prepare a bone socket for the lateral row and bone quality has been assessed, insert an eight gauge open tip, jamshidi through the passport button cannula and into the prepared bone socket. Insert the delivery cannula 2 to 3mm into the socket. The inner trocar is removed and the BoneSync syringe is attached to the delivery cannula. The BoneSync syringe plunger is depressed, delivering the collagen infused calcium phosphate cement. The inner trocar is then reintroduced to clear the cannula and deliver all the material. The medial row sutures are passed through the eyelet of the SwiveLock anchor, which is then secured into the augmented bone socket, where the BoneSync cement interdigitate with the anchor threads. The same steps are completed for the second lateral row anchor. Adding BoneSync calcium phosphate cement to the construct can increase anchor fixation strength. The collagen component of the BoneSync cement brings unique handling characteristics, including stability, and helps to provide the macroporosity structure of the device. This macroporosity structure of the BoneSync cement allows for Osseointegration overall augmenting poor quality bone in the lateral row.

The AutoCart™ procedure provides a simple, reproducible, and cost-effective method for treating symptomatic cartilage defects. Using the GraftNet™ device to collect autologous, particulated cartilage, the AutoCart technique is a single-stage, matrix-augmented approach that can be performed arthroscopically and may improve the degree and quality of tissue healing within a properly prepared articular cartilage defect.1&nbsp;
Reference&nbsp;
1. Salzmann GM, Ossendorff R, Gilat R, Cole BJ. Autologous minced cartilage implantation for treatment of chondral and osteochondral lesions in the knee joint: an overview. Cartilage. 2021;13(1_suppl):1124S-1136S. doi:10.1177/1947603520942952&nbsp;

AutoCart™ Procedure Surgical Technique

The ACP Max™ system provides efficient concentration of platelets and growth factors from platelet-rich plasma (PRP) for use at the patient’s point of care. Expanding on the previous generation of PRP devices, the ACP Max system allows for a larger blood draw and provides increased platelet concentration using a unique double-syringe, double-spin design.&nbsp;

ACP Max™ Platelet-Rich Plasma System

Allograft Tendons A Comprehensive Portfolio Allograft Tendons Overview Since its inception, Arthrex has been committed to one mission: Helping Surgeons Treat Their Patients Better™. We are strategically focused on constant product innovation through scientific research, surgeon collaboration, and medical education to make less invasive surgical procedures simpler, safer, and more reproducible. Our strategic partnerships serve as the industry leaders in procurement, donor screening, and selection criteria. Tissue processing by our partners balances safety with quality by ensuring the preservation of inherent biological properties of the tissue. Our partners provide state-of-the-art processing methods. LifeNet Health’s Allowash XG® has been shown to render a sterility assurance level (SAL) of 10 -6 and to inactivate viruses without compromising the biomechanical or biochemical properties of the tissue.1,2 JRF Ortho’s advanced cleansing technologies maintain tissue integrity with consistent processing, monitored temperature, and limited reagent exposure. Regulatory / Compliance AATB FDA ✔ ✔ CLIA ISO ✔ ✔ The availability of allograft tendons provides surgeons with an invaluable tool for treating a variety of injuries. In the United States, it’s estimated that there are 500,000 knee ligament procedures performed annually,3 including an estimated 300,000 anterior cruciate ligament (ACL) surgeries.4 The Arthrex portfolio of tendons provides surgeons with the widest selection of presutured and standard allograft tendons in the world. Allograft tendons provide many benefits over autograft tendons in reconstructive procedures, such as less donor-site morbidity, fewer incisions, shorter operative time, larger grafts, lower incidence of postoperative arthrofibrosis, and less postoperative pain.4,5 Sterile Tendons Since 2004, Arthrex has been a leading marketer of Allowash XG processed tendons. These tendons have been clinically proven in a variety of surgical applications with an unmatched safety record. The process renders the allografts sterile, without compromising biomechanical or biochemical properties.6-10 Allowash XG Patented and validated process that provides allografts with a SAL of 10 -6 Incorporates 6 steps to ensure sterility Bioburden control Bioburden assessment Minimizing contamination Rigorous cleaning Disinfection and rinsing regimen Terminal sterilization Facilities and environmental controls designed to eliminate cross contamination Uses gentle detergents, antibiotics, and solutions known to be safe on tissue Eliminates blood, lipids, and marrow Flushing Centrifugation Hypotonic processes and ultrasonication Intensive decontamination, disinfection, and scrubbing regimen Designed to eliminate bacteria and viruses Cover histology image courtesy of Dr. Chantelle Bozynski, Thompson Laboratory for Regenerative Orthopaedics, University of Missouri. 02 I Allograft Tendons Tendon Allografts Product Description JRF Ortho Item Number LifeNet Health Item Number Achilles Tendon w/ Bone Block ACT-001 FATB Achilles Tendon w/o Bone Block AWO-001 FAT Anterior Tibialis Tendon, short length, D ≥ 7.5 mm, L = 170 mm-200 mm SAT-001 FANT-SL Posterior Tibialis Tendon, short length, D ≥ 7.5 mm, L = 170 mm-200 mm FPOST-SL Peroneus Longus Tendon, short length, D = 8 mm-11 mm, L = 170 mm-200 mm FPLT-SL Tibialis Tendon, anterior DAT-001 FANT/TIB/T Tibialis Tendon, posterior DPT-001 FPOST.TIBIAL Gracilis, double strand DSG-001 Patellar Tendon, bisected/hemi HPL-001 FBPL WPL-001 FWPL Patellar Tendon, bisected, small block Patellar Tendon, whole FBPLSB Patellar Tendon, whole - small block FWPLSB Patellar Tendon, whole w/ quadriceps FWPLQ Patellar Tendon, whole w/ extensor mechanism FWPLQEXT Peroneus Longus, double strand DSP-001 Peroneus Tendon Preshaped Achilles, 9 mm FPLT ATP-091 Preshaped Achilles, 10 mm ATP-101 FATB10 Preshaped Achilles, 11 mm ATP-111 FATB11 Preshaped Patellar Tendon, 10 mm PLP-101 FPL10 Preshaped Patellar Tendon, 11 mm PLP-111 FPL11 Quadruple Strand Semitendinosus/ Gracilis QSG-001 Quadriceps Tendon w/ Bone QDT-001 Preshaped Quadriceps Tendon, 10 mm QDT-101 Semitendinosus, single strand SST-001 Semitendinosus, double strand DST-001 FQUADB Semitendinosus and Gracilis Tendons 1FST+1FGRACILIS Semitendinosus Tendon, ≥ 230 mm, min D > 4 mm FST Semitendinosus Tendon, L = 160 mm-250 mm, D = 4 mm-6 mm Gracilis Tendon, short length FSTP SSG-001 FGRACILIS Fascia Lata, small, 30 mm × 60 mm FL S Fascia Lata, medium, 30 mm × 150 mm FL M Fascia Lata, large, 80 mm × 200 mm FL L GraftRope FROPE Allograft Tendons I 03 Aseptic Tendons Arthrex offers a full complement of aseptically processed tendons that are never treated with irradiation. Our partner for aseptic tendons, JRF Ortho and its recovery and processing partners, uses extensive evaluation criteria to identify and qualify suitable donors in accordance with American Association of Tissue Banks (AATB) standards. Maximizing safety while providing quality tendons: Aseptically processed allografts are manufactured in a controlled environment with patented methods Use of highly sensitive nucleic acid testing (NAT) Comprehensive donor screening Fluid extraction testing: Advanced cleansing technologies: Designed to cleanse while preserving tissue integrity Proprietary cleansing reduces bioburden without using harsh reagents like hydrogen peroxide Bioburden reduction steps that remove blood and lipids This testing is more accurate because contamination is difficult to detect by swabbing the external surface of the graft Tissue is released after no growth culture results from a validated and highly sensitive fluid membrane filtration test Approximately 35% of all tendons qualify for transplant without the need for ultra-low-dose irradiation Aseptic Tendons Product Description JRF Ortho Item Number Achilles Tendon w/ Bone Block ACT-002 Achilles Tendon w/o Bone Block AWO-002 Achilles Tendon, preshaped, 9 mm (a) ATP-092 Achilles Tendon, preshaped, 10 mm ATP-102 Achilles Tendon, preshaped, 11 mm ATP-112 Hemi-Patellar Ligament HPL-002 Whole-Patellar Ligament WPL-002 Whole-Patellar Ligament w/ Quadriceps WPQ-002 Quadriceps Tendon w/ Bone QDT-001 Quadriceps Tendon w/ Bone, preshaped, 10 mm QDT-102 Patellar Ligament, preshaped, 10 mm (b) PLP-102 Patellar Ligament, preshaped, 11 mm PLP-112 Double Strand Semitendinosus Tendon DST-002 Double Strand Peroneous Longus DSP-002 Double Strand Anterior Tibialis DAT-002 Double Strand Posterior Tibialis DAP-002 Quadruple Strand Semitendinosus/Gracilis QSG-002 Single Strand Semitendinosus Tendon SST-002 Single Strand Anterior Tibialis (c) SAT-002 04 I Allograft Tendons (a) (b) (c) Presutured Tendons Arthrex offers the largest portfolio of presutured tendon allografts for your ligament reconstruction procedures. Presutured tendons are preassembled by qualified tissue technicians for consistency. These tendons are sterilized under low-dose, low-temperature irradiation for patient safety. The convenience of a presutured tendon allows for an off-the-shelf solution with minimal preparation time. Presutured Tendons Product Description JRF Ortho Item Number VersaGraft® Tendon (a) VRG-001 VersaGraft 3.5 Tendon VRG-351 SpeedGraft® Tendon (b) SPD-001 GraftLink® XL Tendon (PCL) GRX-001 LifeNet Health Item Number Allograft GraftLink® Tendon (c) FGL Allograft GraftLink Triple Strand FGLTS QuadLink™ Construct Tendon (d) FQL FlexiGRAFT® Connect Tendon FCON FlexiGRAFT Connect EXT Tendon FCONEXT DualLink Presutured Construct FDL PilotGraft™ BTB Tendon (e) PSP-101 SpeedGraft Achilles Tendon (f) PSA-101 (b) (c) (f) (d) (e) (a) GraftLink Allograft Tendon for All-Inside ACL Reconstruction SpeedGraft Achilles Tendon for ACL Reconstruction VersaGraft Tendon for Lateral Ankle Reconstruction Allograft Tendons I 05 Graft Sizing and Socket Creation Arthrex graft tubes are ideal for sizing and compressing allograft GraftLink® constructs. These full-length, clear tubes facilitate graft compression, sizing, and preparation. Graft Sizing Measure the graft length and diameter. Pass both the femoral and tibial ends of the graft into the sizing block to measure diameter for socket drilling. Socket Creation The length from the end of the femoral socket to the end of the tibial socket should be at least 10 mm longer than the graft to ensure the graft can be tensioned fully. Example: 70 mm length Allograft QuadLink™ Construct The QuadLink construct is a presized and preassembled allograft quadriceps tendon presutured with #2 FiberLoop with FiberTag™ suture, designed to be used with ACL TightRope® implants. The all-inside ACL technique is ideal for quadriceps grafts, as only a graft length of 60 mm to 75 mm is needed. ACL TightRope II implants are used to fixate the graft in minimally invasive sockets created with a FlipCutter® III drill. A standard all-inside technique is used to implant the graft. QuadLink presutured constructs are preassembled by qualified technicians that have trained and certified to ensure construct consistency. The tendons are provided as a sterile allograft construct via the Allowash XG process for patient and surgeon safety. 06 I Allograft Tendons Allograft QuadLink Construct Features and Benefits: Minimal graft preparation time Presized diameter and lengths Allowash XG technology Preassembled with #2 FiberLoop with FiberTag suture Preloaded with passing sutures to facilitate loading with ACL TightRope II implants Allograft GraftLink® Construct Consisting of preconstructed allograft tendon, GraftLink constructs are designed for use with the GraftLink ACL technique and TightRope® implants. Each construct is precisely assembled according to Arthrex specifications by trained tissue technicians to ensure it meets the requirements of the GraftLink technique and allows for an anatomic, minimally invasive, and reproducible ACL reconstruction. Allograft GraftLink Construct Features and Benefits: Allowash XG technology Preassembled with #2 FiberWire® suture Minimal graft preparation time Presized to specifications of GraftLink all-inside ACL technique Preloaded with passing sutures to facilitate loading of ACL TightRope implants The constructs are rendered sterile using the Allowash XG process, a patented and proprietary sterilization process with a high degree of safety that achieves an SAL of 10 -6 without compromising biological and biomechanical properties. Since 1995, more than 6 million bioimplants processed using Allowash technology have been distributed with no disease transmission.1 PilotGraft™ BTB Tendon PilotGraft BTB tendons are preshaped, predrilled, bonetendon-bone allografts that can be used in ACL and PCL reconstruction procedures. Two preshaped 10 mm bone block, each with a 2 mm predrilled hole through the bone, facilitate insertion into bone tunnels. Looped #2 FiberLoop® suture is preinserted through the tunnels to help with suture shuttling. It can be removed if securing the tendon with an interference screw. Bone dowels are available in lengths from 20 mm to 30 mm. Available intra-articular lengths range from 25 mm to 45 mm and can be selected based on surgeon requirements. PilotGraft BTB Tendon Features and Benefits: Multiple size options (65 mm to 95 mm total length) No donor-site morbidity 3-year shelf life Sterile (10 -6 SAL) Allograft Tendons I 07 SpeedGraft® Achilles Tendon This presutured Achilles tendon, which includes a bone block predrilled with a 2 mm tunnel, provides for boneto-bone fixation on the femoral side and efficient softtissue fixation on the tibial side. Looped #2 FiberLoop® suture is preinserted through the tunnel to help with suture shuttling. It can be removed if securing the tendon with an interference screw. SpeedGraft Presutured Double Strand Tendon Designed for use with the ACL TightRope® implant for ACL and PCL reconstructions, the SpeedGraft allograft is a presutured, double strand, sterile tendon with individually sutured tails that can be identified by their color. This design allows for multiple fixation methods, providing flexibility for the surgeon. SpeedGraft Tendon Features and Benefits: Each tendon is assembled according to Arthrex specifications, by trained tissue technicians, ensuring that the presutured tendon meets the requirements of the procedure to allow for an anatomic, minimally invasive, and reproducible ACL or PCL reconstruction. SpeedGraft presutured tendons are processed with a validated and patented cleaning treatment designed to facilitate the removal of cellular elements from tissue while maintaining the structural integrity of the allograft. This process has been proven to reduce the potential danger of disease transmission by removing over 99% of blood, lipids, and marrow from the allograft. The incorporation of a rigorous donorscreening process and terminal sterilization enhances the safety of this allograft tendon. ACL TightRope RT Implant Graft: Sterile allograft tendon ACL/PCL 08 I Allograft Tendons Preassembled with #2 FiberLoop® and #2 TigerLoop® suture Minimal preparation time 10 -6 SAL for patient safety Use with ACL TightRope RT implant Presized lengths and diameters for patient customization Tendon lengths: 175 mm to 295 mm Tendon diameters: 8 mm to 11 mm Double Stranded: FiberLoop suture TigerLoop suture VersaGraft® Tendon The VersaGraft presutured tendon is a preassembled, presized, sterile allograft tendon with simple tensioning and rigid fixation that can be used for anatomic reconstruction of the anterior talofibular (ATFL) and calcaneofibular (CFL) ligaments. All tendons are precisely assembled by highly trained tissue technicians, according to Arthrex specifications, to ensure each construct meets the requirements of the lateral ankle reconstruction technique. Potential Applications Medial patellofemoral ligament (MPFL) Patellar tendon repair Medial collateral ligament (MCL) Elbow ligament repair Lateral collateral ligament (LCL) Lateral ankle stabilization Medial deltoid reconstruction Anterolateral ligament (ALL) reconstruction Acromioclavicular (AC) joint reconstruction Diameter: 4.5 mm ± .5 mm Lengths: 150 mm - 250 mm ALL Reconstruction Allograft Tendons I 09 VersaGraft® 3.5 mm Tendon The VersaGraft 3.5 mm presutured tendon provides time and cost savings to physicians. Presutured tendon constructs are sterile and preassembled with Arthrex sutures for speed and convenience. Each construct is assembled according to Arthrex specifications, by trained technicians, ensuring that the presutured tendon construct meets the requirements of the procedure to allow for anatomic, minimally invasive, and reproducible reconstruction. Commonly used for MPFL reconstructions, the VersaGraft 3.5 tendon comes preassembled with #0 FiberLoop® suture and has a diameter of 3.5 mm to 4.5 mm and length of 190 mm to 240 mm. 10 I Allograft Tendons FlexiGraft® Connect™ Tendon FlexiGraft Connect EXT Tendon The FlexiGraft Connect tendon is presutured with #2 FiberLoop® suture for 15 mm to 19 mm of length on one end and a locking tag stitch on the opposite end. The tendon has a diameter of 4.5 mm ± 0.5 mm and a length of 150 mm to 250 mm. This small-diameter, presutured tendon is can be used for distal extremity procedures such as metatarsophalangeal joint reconstruction, distal extremity tendon transfer, elbow and thumb ulnar collateral ligament (UCL) procedures, hallux varus/ valgus reconstruction, spring ligament reconstruction, and scapholunate ligament reconstruction. It’s similar in design to the FlexiGraft Connect tendon but smaller in diameter and suture size. References 1. Moore MA. Inactivation of enveloped and non-enveloped viruses on seeded human tissues by gamma irradiation. Cell Tissue Bank. 2012;13(3):401-407. doi:10.1007/s10561-011-9266-0 2. LifeNet Health. Data on file (TR-0020, TR-0023). Virginia Beach, VA. 3. SmartTRAK Market Research, Graft Market – US, 2018. 4. Garrett WE, Jr, Swiontkowski MF, Weinstein JN, et al. American Board of Orthopaedic Surgery practice of the orthopaedic surgeon: part II. Certification examination case mix. J Bone Joint Surg Am. 2006;88:660-667. doi:10.2106/JBJS.E.01208 5. Edgar CM, Zimmer S, Kakar S, Jones H, Schepsis AA. Prospective comparison of auto and allograft hamstring tendon constructs for ACL reconstruction. Clin Orthop Relat Res. 2008;466(9):2238-2246. doi:10.1007/s11999008-0305-5 6. Samsell BJ, Moore MA. Use of controlled low dose gamma irradiation to sterilize allograft tendons for ACL reconstruction: biomechanical and clinical perspective. Cell Tissue Bank. 2012;13(2):217-23. doi:10.1007/ s10561-011-9251-7 7. Balsly CR, Cotter AT, Williams LA, Gaskins BD, Moore MA, Wolfinbarger L Jr. Effect of low dose and moderate dose gamma irradiation on the mechanical properties of bone and soft tissue allografts. Cell Tissue Bank. 2008;9(4):289-98. doi:10.1007/s10561-008-9069-0 8. Tejwani SG, Chen J, Funahashi TT, Love R, Maletis GB. Revision risk after allograft anterior cruciate ligament reconstruction: association with graft processing techniques, patient characteristics, and graft type. Am J Sports Med. 2015;43(11):2696-705. doi:10.1177/0363546515589168 9. Greaves LL, Hecker AT, Brown CH Jr. The effect of donor age and low-dose gamma irradiation on the initial biomechanical properties of human tibialis tendon allografts. Am J Sports Med. 2008;36(7):1358-66. doi:10.1177/0363546508314394 10. Rihn JA, Irrgang JJ, Chhabra A, Fu FH, Harner CD. Does irradiation affect the clinical outcome of patellar tendon allograft ACL reconstruction?. Knee Surg Sports Traumatol Arthrosc. 2006;14(9):885-96. doi:10.1007/s00167006-0036-7 Allograft Tendons I 11 Allowash XG technology is a registered trademark of LifeNet Health. This description of technique is provided as an educational tool and clinical aid to assist properly licensed medical professionals in the usage of specific Arthrex products. As part of this professional usage, the medical professional must use their professional judgment in making any final determinations in product usage and technique. In doing so, the medical professional should rely on their own training and experience, and should conduct a thorough review of pertinent medical literature and the product’s directions for use. Postoperative management is patient-specific and dependent on the treating professional’s assessment. Individual results will vary and not all patients will experience the same postoperative activity level and/or outcomes. View U.S. patent information at www.arthrex.com/corporate/virtual-patent-marking arthrex.com © 2024-06 Arthrex, Inc. All rights reserved. LB1-000090-en-US_C

Allograft Tendons: A Comprehensive Portfolio

Gian Salzmann, MD (Zurich, Switzerland), presents a case in which he treated a young athlete with a full-thickness cartilage defect of the patella using the AutoCart™ procedure. Prof. Salzmann discusses his rehabilitation protocol and the patient considerations that helped support an excellent outcome.

Surgeons presenting one or more clinical cases

Chirurg:innen präsentieren einen oder mehrere klinische Fälle

Videos von Fallpräsentationen

Cirurgiões que apresentam um ou mais casos clínicos.

Vídeos apresentações de casos

Cirujanos que presentan uno o más casos clínicos.

Video presentaciones de casos

Case Presentation Videos

AutoCart™ Procedure: Case Presentation in a Young Athlete

Hi, my name is John Saltzman. I'm a consultant knee surgeon from Germany as well as Switzerland. Today I'm going to talk about a specific AutoCart procedure in a pediatric athlete. The patient came to my office. She is a 12 year old female sporting, very active, playing volleyball and playing soccer. She was reporting to me about chronic patella subluxation on both knee joints with in the last couple months, pain and inability to perform sporting activities. And in the recent weeks, she had a further significant sub or even full luxation at her left knee joint, which increased the pain at that knee joint. And on top of that, some clicking phenomena. The clinical findings were that she had a clear valgus deformity at both lower extremities, and she had a clear dynamic valgus when she was walking. She had a both sided positive apprehension sign, which was positive up to 65 degrees of knee flexion. She had a slightly elevated BMI with a slightly fat thigh, which is even producing more valgus deformity, and on her left knee joint she had a very clear patella clicking and increased pain during movement. On initial x ray analysis AP view, you saw more or less normal knee joint with a slight patella Alta position and open growth plates on the tibia, as well as on the femur bone. But when performing full length x rays, we saw that she had a very clear valgus deformity concurring to the clinical findings, which was on her right leg a little more than on her left leg, which was six degrees of valgus on her right side and four degrees of valgus on her left side. We performed MRI of both knee joints and saw a more or less normal MRI on her right knee joint with a with a good patellofemoral articulation on a left MRI Patellofemoral view axial section. We saw also a pretty good patellofemoral joint, but some effusion, some excessive joint fluid and the full thickness delaminated cartilage flap at the medial patellar facet which was causing her clicking phenomena, which is clearly seen on that image we performed in this case also a dynamic 4D gait analysis to see if the dynamic valgus is even more when comparing to the X-rays. But we saw here that the valgus under walking is exactly the same, or has been exactly the same as when comparing to the X-rays. In summary, the patient had a two sided patellar instability, a valgus deformity with still open growth plates on the femur as well as on the tibia. She had a full thickness symptomatic cartilage defect on her left patella, so we proceeded with operative surgery on a left knee joint. We performed a standard diagnostic arthroscopy and under arthroscopy we saw that delaminated cartilage flap, which is, from our standpoint, still vital. So we choose to collect that cartilage flap using a designated device and collected that cartilage in the GraftNet tissue collector. Then we could monitor how much cartilage we had collected, which in this case was enough for transplantation because after debridement, the cartilage defect was not larger than two square centimeters. After preparation of the defect and stabilizing the defect edges and clearing out the subchondral bone, which was intact and the opposing trochlea was also intact, we dried out the knee joint and performed an extra very far proximal medial portal. And then we put in a tissue swab to have some capsular distention also to prevent further bleeding. And then we were in a perfect setup to perform a fully arthroscopic AutoCart procedure at a medial patella, using the cartilage flap that has been previously delaminated. We fixed that by autologous fibrin and had a very nice final product which was stable under full flexion extension maneuvers. Post-operatively. It was a minimally invasive approach, 30 minutes on every leg, and the patient was doing fine after surgery. So far, the rehabilitation in this case was a fully functional rehabilitation on the right side. On the left side, we decided to perform three weeks partial weight bearing at 15kg and limited range of motion to 30 degrees in the first two weeks 60 degrees week three and four, and to 90 degrees week five and six. And we progressed to full weight bearing commenced at four weeks, and at six weeks we allowed the allowed the patient to return to biking and swimming slowly. Ten weeks after the operation, to return to running, 5 to 6 months after the operation, and we started sports specific training, in this case meaning volleyball and soccer at six months, with a return to full competition and contact sports 12 months after the operation. The case summary here would be. This has been a fully minimally invasive, all at once purely autologous biologic approach at both knee joints, with a quick rehabilitation with the idea to have straight legs, which means also at the same time have patella stability and with a good as possible cartilage repair at the patella. But using the AutoCart approach under arthroscopic settings on the left knee joint in this case. We are very optimistic in that. Thank you very much.

Arthrex offers a variety of tendon allografts, including a wide portfolio of presutured tendons, for primary and revision ligament reconstruction procedures. This animation highlights the comprehensive presutured allograft tendon portfolio and potential applications.&nbsp;

Presutured Construct Tendons

Knee

The BioACL™ technique augments ACL reconstruction with an unmatched combination of the patient’s own biology, the highest-quality biologics, and the proven technology of the QuadLink™ technique with the InternalBrace™ procedure to maximize healing potential.&nbsp;
 
The InternalBrace surgical technique is intended only to augment the primary repair/reconstruction by expanding the area of tissue approximation during the healing period and is not intended as a replacement for the native ligament. The InternalBrace technique is for use during soft tissue-to-bone fixation procedures and is not cleared for bone-to-bone fixation.

BioACL™ Technique Animation

A step-by-step demonstration of how a product would (or could) be used in a surgical technique.

Eine schrittweise Demonstration, wie ein Produkt in einer Operationsanleitung verwendet werden würde (oder könnte).

Operationsanleitungen

Demonstração passo a passo de como um produto seria utilizado em uma técnica cirúrgica.

Guias de técnicas cirúrgicas

Demostración paso a paso de cómo se utilizaría un producto en una técnica quirúrgica.

Guías de técnicas quirúrgicas

Surgical Technique Guides

GraftNet XL Bone Collection Device ™ Surgical Technique for Spine Applications GraftNet™ XL Bone Collection Device Simplified Autologous Bone Graft Collection The GraftNet XL device is designed to maximize autologous bone graft collection and uses a large-volume mesh collection filter to easily integrate the patient’s own cells into the procedure. Clip for attaching and securing the device onto the sterile field Universal suction and shaver adapters Technique 1 Attach the GraftNet XL tubing to the desired handpiece or Frasier tip suction device. Attach outflow tubing to the outflow adapter of the GraftNet XL device. 02 I GraftNet™ XL Bone Collection Device 2 Continue with resection as desired. Collected autologous collected tissue will be captured in the inner filter of the GraftNet XL device. 3 Once bone collection is complete, disconnect the device from suction and twist the cap from the locked to the unlocked position and remove the inner filter. 4 5 Excess fluid can be removed from the collected bone material by squeezing the mesh filter or using a sterile absorbent pad. Invert the filter to remove the autologous bone and place into a sterile basin. A Freer elevator can be used to remove additional autologous bone from the filter. Potential Applications Spinal Fusion Craniotomy The GraftNet™ XL device can be used to collect bone during any procedure where there is a desire to capture and reintegrate autologous bone into the reconstruction or repair, such as a laminectomy or craniotomy. Universal adaptors at inflow and outflow ensure the GraftNet XL device can be quickly incorporated into any spine or neurosurgery procedure. GraftNet™ XL Bone Collection Device I 03 Ordering Information Product description Item number GraftNet™ XL bone collection device ABS-1052 This description of technique is provided as an educational tool and clinical aid to assist properly licensed medical professionals in the usage of specific Arthrex products. As part of this professional usage, the medical professional must use their professional judgment in making any final determinations in product usage and technique. In doing so, the medical professional should rely on their own training and experience, and should conduct a thorough review of pertinent medical literature and the product’s directions for use. Postoperative management is patient-specific and dependent on the treating professional’s assessment. Individual results will vary and not all patients will experience the same postoperative activity level or outcomes. arthrex.com © 2025-02 Arthrex Inc. All rights reserved. LT1-000294-en-US_D Arthrex manufacturer, authorized representative, and importer information (Arthrex eIFUs) US patent information

GraftNet™  XL Bone Collection Device - Surgical Technique for Spine Applications

A comprehensive overview of a product team’s portfolio.

Ein umfassender Überblick über das Portfolio eines Produktteams.

Kataloge

Visão geral e abrangente do portfólio de produtos de cada segmento.

Catálogos

Descripción general y completa sobre la cartera de productos de cada segmento. 

Catalogs

Orthobiologics - Next Generation in Biologics Technology

Chirurgen-Newsletter

Boletins para cirurgiões

Boletines para cirujanos

Surgeon Newsletters

Scope This Out Volume 25 Number 2

Quick Facts AutoCart™ Technique Single-Stage, Arthroscopic Cartilage Restoration Using the Patient’s Own Cells Microfracture alone is not a long-term answer. Only 58% return to sport at 2 years postprocedure.1 20.9% reoperation rate with microfracture at 2 years.2 Augmentation with BioCartilage® extracellular matrix (ECM) in the AutoCart technique can: Improve functional outcomes3 Improve reparative tissue and result in low reoperation rate2 Particulate cartilage chips provide increased surface area, better outgrowth, and better ECM production.4 Collection of central or peripheral cartilage with the GraftNet™ device can lead to increased cartilage quality and viability.1 The AutoCart graft preserves the pericellular matrix (PCM), containing the proteins to drive chondrogenesis.5 At 2 years, the AutoCart procedure can lead to significant improvements in patient-reported outcomes.6 KOOS total 80 75 70 65 60 Preoperative 3 months 62.4 at baseline 6 months | 12 months 24 months 74.4 at 2 years post-op References 1. Krych AJ, Pareek A, King AH, Johnson NR, Stuart MJ, Williams RJ 3rd. Return to sport after the surgical management of articular cartilage lesions in the knee: a meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2017;25(10):3186-3196. doi:10.1007/s00167-016-4262-3 2. Drakos MC, Eble SK, Cabe TN, et al. Comparison of functional and radiographic outcomes of talar osteochondral lesions repaired with micronized allogenic cartilage extracellular matrix and bone marrow aspirate concentrate vs microfracture. Foot Ankle Int. 2021;42(7):841-850. doi:10.1177/1071100720983266 3. Cole BJ, Haunschild ED, Carter T, et al. Clinically significant outcomes following the treatment of focal cartilage defects of the knee with microfracture augmentation using cartilage allograft extracellular matrix: a multicenter prospective study. Arthroscopy. 2021;37(5):1512-1521. doi:10.1016/j.arthro.2021.01.043 4. Bonasia DE, Marmotti A, Mattia S, et al. The degree of chondral fragmentation affects extracellular matrix production in cartilage autograft implantation: an in vitro study. Arthroscopy. 2015;31(12):2335-2341. doi:10.1016/j.arthro.2015.06.025 5. Ossendorff R, Walter SG, Schildberg FA, et al. Biologic principles of minced cartilage implantation: a narrative review. Arch Orthop Trauma Surg. 2023;143(6):3259-3269. doi:10.1007/s00402-022-04692-y 6. Schneider S, Ossendorff R, Walter SG, et al. Arthroscopic autologous minced cartilage implantation of cartilage defects in the knee: a 2-year follow-up of 62 patients. Orthop J Sports Med. 2024;12(12):23259671241297970. doi:10.1177/23259671241297970 7. Runer A, Ossendorff R, Öttl F, et al. Autologous minced cartilage repair for chondral and osteochondral lesions of the knee joint demonstrates good postoperative outcomes and low reoperation rates at minimum five-year follow-up. Knee Surg Sports Traumatol Arthrosc. 2023;31(11):4977-4987. doi:10.1007/s00167-023-07546-1 arthrex.com © 2025-02 Arthrex, Inc. All rights reserved. LI1-000190-en-US_A At 5-year follow-up, patients who underwent the AutoCart procedure showed significant improvement in pain and function and a 3.5% revision rate in the knee.7